NCT01608542View on ClinicalTrials.gov

A Single and Multiple Dose Study to Assess Blood and Urine Drug Levels of Fostamatinib in Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Healthy Japanese Volunteers
Interventions
DRUG

Fostamatinib 100mg

oral tablet

DRUG

Fostamatinib 200mg

oral tablet

Trial Locations (2)

Unknown

Glendale

Baltimore

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY